Drugs are developed for the “average patient,” even though there’s no such thing, and patients are prescribed drug after drug until, hopefully, they find one that works. Meanwhile, their lives are put on hold while their diseases worsen and billions of dollars are wasted on therapies that don’t work.
Now, with our breakthrough ability to determine which drug will work best for each patient, we can do better to advance precision medicine in autoimmune diseases.
Through a simple blood test, we interpret a patient’s own RNA data to determine which drug will work best, from day one.
Our platform uses the largest protein interaction database ever built to understand diseases and how to treat them.
Fueled by our platform and the data from our diagnostics, we identify novel targets for new therapies and the appropriate patient population who is more likely to respond to the drug